Latest News

Journal Articles

Autoimmune

Autoantibodies in neurological disorders – a review from Judith Greer

Immunotherapy for mild cognitive impairment patients: a role for omega-3 fatty acids in improving innate immunity against amyloid-beta

NCTalks with Robyn Klein: immunology and inflammation in neurological disease

Cerebrovascular disease

Spider venom affords neuroprotection after stroke

Orthostatic hypotension could contribute to risk of dementia

Post-stroke neurogenesis boosted with new compound

CNS/PNS/SNS

Spinal muscular atrophy may be caused by synaptic abnormalities

#NCintroduces… Mammalian chronobiology and circadian rhythms

The future of neuromodulation: an interview with Timothy Deer, President of the International Neuromodulation Society

Cognitive/neurodegenerative disorders

Management of glaucoma as a neurodegenerative disease

NCTalks at AAN 2017: Michael Alosco on CTE and the search for an in vivo diagnosis

Spinal muscular atrophy may be caused by synaptic abnormalities

Demyelinating disease

NCTalks at AAN 2017: Michael Pender on a new multiple sclerosis treatment targeting Epstein-Barr virus

New research takes us a step forward in the fight to understanding multiple sclerosis

IL4I1 decreases inflammation and promotes CNS repair in models of multiple sclerosis

Development and pediatrics

Spinal muscular atrophy may be caused by synaptic abnormalities

AAN 2017: Two clinical studies report promising data for new spinal muscular atrophy treatment

First live-attenuated Zika vaccine induces protective immunity in mice

Epilepsy and seizure

Epilepsy drug receives approval as monotherapy from European Medicines Agency

The future of neuromodulation: an interview with Timothy Deer, President of the International Neuromodulation Society

Scientists discover ‘silent seizures’ in Alzheimer’s disease patients

Genetics

Understanding epigenetics of schizophrenia in the backdrop of its antipsychotic drug therapy

Stem cell-derived neurons in the development of targeted treatment for schizophrenia and bipolar disorder

Is there a role for pharmacogenetics in the dosing of fentanyl?

Headache

Noninvasive brain stimulation: an interview with Eric Wasserman

Electrical stimulation could provide pain relief alternative for migraines

Psychological mislabeling of chronic pain: lessons from migraine in the 20th century

Immune disorders and inflammation

NCTalks at AAN 2017: Michael Pender on a new multiple sclerosis treatment targeting Epstein-Barr virus

Autoantibodies in neurological disorders – a review from Judith Greer

Immunotherapy for mild cognitive impairment patients: a role for omega-3 fatty acids in improving innate immunity against amyloid-beta

Infection

Zika virus to be investigated as novel glioblastoma treatment

NCTalks at AAN 2017: Michael Pender on a new multiple sclerosis treatment targeting Epstein-Barr virus

Researchers uncover how Zika virus might cross the placental barrier

Injury/trauma

NCTalks at AAN 2017: Michael Alosco on CTE and the search for an in vivo diagnosis

Auditory comprehension performance of college students with and without sport concussion on Computerized-Revised Token Test Subtest VIII

Antidepressant drugs could be repurposed to prevent TBI-induced neuronal damage

Movement disorders

Essential tremor patient successfully treated with MR-guided focused ultrasound treatment

The future of neuromodulation: an interview with Timothy Deer, President of the International Neuromodulation Society

AAN17: Phase III study reports the positive effects of an “old” drug for the treatment of advanced Parkinson’s disease

Neuro-ophthalmology

Management of glaucoma as a neurodegenerative disease

Genetic analysis identifies loci associated with macular telangiectasia type 2

The best of 2016 on Neurology Central – a note from the Editor

Neurometabolic

Could the gut microbiome hold the key to neurodegenerative disorders?

The best of 2016 on Neurology Central – a note from the Editor

Energy drinks and alcohol may affect adolescent brains in similar way to cocaine

Neuromuscular

Spinal muscular atrophy may be caused by synaptic abnormalities

Mitochondrial DNA homeostasis dysregulated in Parkinson’s disease

Antibody show promise against multiple sclerosis

Neuropsychiatry

Understanding epigenetics of schizophrenia in the backdrop of its antipsychotic drug therapy

Antidepressant drugs could be repurposed to prevent TBI-induced neuronal damage

Stem cell-derived neurons in the development of targeted treatment for schizophrenia and bipolar disorder

Oncology/tumor

Zika virus to be investigated as novel glioblastoma treatment

European Commission approves first immunotherapy for high-risk neuroblastoma patients

Current update of adoptive immunotherapy using cytokine-induced killer cells to eliminate malignant gliomas

Pain

The future of neuromodulation: an interview with Timothy Deer, President of the International Neuromodulation Society

Toward an etiology-based management of trigeminal neuralgia

Noninvasive brain stimulation: an interview with Eric Wasserman

Sleep

#NCintroduces… Mammalian chronobiology and circadian rhythms

Webinar Q&A follow-up: How chronic stress experienced during early development epigenetically programs adult disease risk

Precision medicine in circadian rhythm sleep–wake disorders: current state and future perspectives